TY - JOUR
T1 - Ribophorin ii is involved in the tissue factor expression mediated by phosphatidylserinedependent antiprothrombin antibody on monocytes
AU - Fujieda, Yuichiro
AU - Amengual, Olga
AU - Matsumoto, Masaki
AU - Kuroki, Kimiko
AU - Takahashi, Hidehisa
AU - Kono, Michihito
AU - Kurita, Takashi
AU - Otomo, Kotaro
AU - Kato, Masaru
AU - Oku, Kenji
AU - Bohgaki, Toshiyuki
AU - Horita, Tetsuya
AU - Yasuda, Shinsuke
AU - Maenaka, Katsumi
AU - Hatakeyama, Shigetsugu
AU - Nakayama, Keiichi I.
AU - Atsumi, Tatsuya
N1 - Publisher Copyright:
© The Author 2016.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Objective. Phosphatidylserine-dependent, also called aPS-PT, recognizes the phosphati dylserine prothrombin complex, which is associated with APS. We have previously reported that aPSPT induces tissue factor (TF) expression on monocytes through the p38 mitogen-activated protein kinase pathway. However, the cell surface interaction between prothrombin and aPS-PT, which is involved in the activation of cell-signalling pathways, has remained unknown. The objective of this study was to identify membrane proteins involved in the binding of prothrombin and aPS-PT to monocyte surfaces as well as the induction of TF expression. Methods. RAW264.7 cells with FLAG-tagged prothrombin were incubated and separated using affinity chromatography with anti-FLAG antibody-conjugated Sepharose beads. Immunopurified proteins were then analysed by an online nano-liquid chromatography tandem mass spectrometry. The binding between prothrombin and the identified protein, ribophorin II (RPN2), was analysed by ELISA and surface plasmon resonance. To elucidate the role of RPN2 in TF expression, the TF mRNA level in RAW264.7 cells treated with RPN2 small interfering RNA was determined by quantitative real-time PCR (qPCR). Results. RPN2 was identified as a candidate molecule involved in the binding of prothrombin to the cell surface. The binding between prothrombin and RPN2 was confirmed by ELISA and surface plasmon resonance. RAW264.7 cells treated with RPN2 small interfering RNA showed significant reduction of the TF expression mediated by prothrombin and a mouse monoclonal aPS-PT. Conclusion. We identified that RPN2 is one of the prothrombin-binding proteins on monocyte surfaces, suggesting that RPN2 is involved in the pathophysiology of thrombosis in patients with APS.
AB - Objective. Phosphatidylserine-dependent, also called aPS-PT, recognizes the phosphati dylserine prothrombin complex, which is associated with APS. We have previously reported that aPSPT induces tissue factor (TF) expression on monocytes through the p38 mitogen-activated protein kinase pathway. However, the cell surface interaction between prothrombin and aPS-PT, which is involved in the activation of cell-signalling pathways, has remained unknown. The objective of this study was to identify membrane proteins involved in the binding of prothrombin and aPS-PT to monocyte surfaces as well as the induction of TF expression. Methods. RAW264.7 cells with FLAG-tagged prothrombin were incubated and separated using affinity chromatography with anti-FLAG antibody-conjugated Sepharose beads. Immunopurified proteins were then analysed by an online nano-liquid chromatography tandem mass spectrometry. The binding between prothrombin and the identified protein, ribophorin II (RPN2), was analysed by ELISA and surface plasmon resonance. To elucidate the role of RPN2 in TF expression, the TF mRNA level in RAW264.7 cells treated with RPN2 small interfering RNA was determined by quantitative real-time PCR (qPCR). Results. RPN2 was identified as a candidate molecule involved in the binding of prothrombin to the cell surface. The binding between prothrombin and RPN2 was confirmed by ELISA and surface plasmon resonance. RAW264.7 cells treated with RPN2 small interfering RNA showed significant reduction of the TF expression mediated by prothrombin and a mouse monoclonal aPS-PT. Conclusion. We identified that RPN2 is one of the prothrombin-binding proteins on monocyte surfaces, suggesting that RPN2 is involved in the pathophysiology of thrombosis in patients with APS.
UR - http://www.scopus.com/inward/record.url?scp=84974793178&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84974793178&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/kew005
DO - 10.1093/rheumatology/kew005
M3 - Article
C2 - 26895716
AN - SCOPUS:84974793178
SN - 1462-0324
VL - 55
SP - 1117
EP - 1126
JO - Rheumatology and Rehabilitation
JF - Rheumatology and Rehabilitation
IS - 6
ER -